Green plants, cool tones, casually placed scatter cushions: this living room in East Melbourne could belong to – or at least, be rented by – any millennial. The squeaky corridor floors are a giveaway, though; along with the beds on wheels.
This isn’t a real estate opportunity, but Doherty Clinical Trials (DCT) – Australia’s first unit dedicated to human challenge studies, where trial participants are given a dose of an infectious disease in a controlled setting. An offshoot of the Peter Doherty Institute for Infection and Immunity at the University of Melbourne, it opens on Monday – a breeding ground, its proprietors hope, for discoveries that may redefine the future of disease.
